Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Department of Pediatrics, University of Tokyo, Tokyo, Japan.
J Med Genet. 2019 Jun;56(6):413-418. doi: 10.1136/jmedgenet-2018-105463. Epub 2018 Sep 21.
Recently, a patient with maternal uniparental disomy of chromosome 16 (UPD(16)mat) presenting with Silver-Russell syndrome (SRS) phenotype was reported. SRS is characterised by growth failure and dysmorphic features.
To clarify the prevalence of UPD(16)mat in aetiology-unknown patients with SRS phenotype and phenotypic differences between UPD(16)mat and SRS.
We studied 94 patients with SRS phenotype of unknown aetiology. Sixty-three satisfied the Netchine-Harbison clinical scoring system (NH-CSS) criteria, and 25 out of 63 patients showed both protruding forehead and relative macrocephaly (clinical SRS). The remaining 31 patients met only three NH-CSS criteria, but were clinically suspected as having SRS. To detect UPD(16)mat, we performed methylation analysis for the :TSS-differentially methylated region (DMR) on chromosome 16 and subsequently performed microsatellite, SNP array and exome analyses in the patients with hypomethylated :TSS-DMR.
We identified two patients (2.1%) with a mixture of maternal isodisomy and heterodisomy of chromosome 16 in 94 aetiology-unknown patients with SRS phenotype. Both patients exhibited preterm birth and prenatal and postnatal growth failure. The male patient had ventricular septal defect and hypospadias. Whole-exome sequencing detected no gene mutations related to their phenotypes.
We suggest considering genetic testing for UPD(16)mat in SRS phenotypic patients without known aetiology.
最近,有一位患有母源单亲二体 16 号染色体(UPD(16)mat)并表现出 Silver-Russell 综合征(SRS)表型的患者被报道。SRS 的特征是生长发育迟缓及畸形。
明确在病因不明的 SRS 表型患者中 UPD(16)mat 的发生率,以及 UPD(16)mat 与 SRS 之间的表型差异。
我们研究了 94 例病因不明的 SRS 表型患者。其中 63 例符合 Netchine-Harbison 临床评分系统(NH-CSS)标准,并且 63 例中有 25 例患者表现出前额头突出和相对大头畸形(临床 SRS)。其余 31 例患者仅符合 NH-CSS 标准中的 3 条,但临床上疑似患有 SRS。为了检测 UPD(16)mat,我们对 16 号染色体上的:TSS 差异甲基化区域(DMR)进行了甲基化分析,随后对低甲基化:TSS-DMR 的患者进行了微卫星、SNP 阵列和外显子分析。
我们在 94 例病因不明的 SRS 表型患者中发现了 2 例(2.1%)患者存在 16 号染色体母源同二体和异二体的混合情况。这 2 例患者均表现为早产以及产前和产后生长发育迟缓。男性患者还患有室间隔缺损和尿道下裂。全外显子组测序未检测到与他们表型相关的基因突变。
我们建议对于病因不明的 SRS 表型患者,考虑进行 UPD(16)mat 的基因检测。